Results 41 to 50 of about 9,597 (210)

Field evaluation of a rapid immunochromatographic dipstick test for the diagnosis of cholera in a high-risk population. [PDF]

open access: yes, 2006
BACKGROUND: Early detection of cholera outbreaks is crucial for the implementation of the most appropriate control strategies. METHODS: The performance of an immunochromatographic dipstick test (Institute Pasteur, Paris, France) specific for Vibrio ...
Park, T.   +47 more
core   +1 more source

Long-term effectiveness of one and two doses of a killed, bivalent, whole-cell oral cholera vaccine in Haiti: an extended case-control study

open access: yesThe Lancet Global Health, 2018
Summary: Background: No study of long-term protection following killed oral cholera vaccination has been done outside of the historically cholera-endemic areas of south Asia, or has examined protection after a single-dose vaccination regimen. To address
Molly F Franke, ScD   +5 more
doaj   +1 more source

Population-Level Effect of Cholera Vaccine on Displaced Populations, South Sudan, 2014

open access: yesEmerging Infectious Diseases, 2016
Following mass population displacements in South Sudan, preventive cholera vaccination campaigns were conducted in displaced persons camps before a 2014 cholera outbreak.
Andrew S. Azman   +13 more
doaj   +1 more source

Live attenuated oral cholera vaccines

open access: yesExpert Review of Vaccines, 2006
Live, orally administered, attenuated vaccine strains of Vibrio cholerae have many theoretical advantages over killed vaccines. A single oral inoculation could result in intestinal colonization and rapid immune responses, obviating the need for repetitive dosing. Live V.
Edward T, Ryan   +2 more
openaire   +2 more sources

Evaluation and use of surveillance system data toward the identification of high-risk areas for potential cholera vaccination: a case study from Niger. [PDF]

open access: yes, 2012
In 2008, Africa accounted for 94% of the cholera cases reported worldwide. Although the World Health Organization currently recommends the oral cholera vaccine in endemic areas for high-risk populations, its use in Sub-Saharan Africa has been limited ...
Grais, R   +17 more
core   +2 more sources

Oral cholera vaccines and their impact on the global burden of disease

open access: yesHuman Vaccines & Immunotherapeutics, 2019
With one-third of nations at risk of cholera, we can expect to experience massive, rapidly disseminated, and prolonged cholera outbreaks such as those recently experienced in Yemen and Haiti.
Thomas F. Wierzba
doaj   +1 more source

Transient Facial Nerve Paralysis (Bell's Palsy) following Intranasal Delivery of a Genetically Detoxified Mutant of Escherichia coli Heat Labile Toxin. [PDF]

open access: yes, 2009
BACKGROUND: An association was previously established between facial nerve paralysis (Bell's palsy) and intranasal administration of an inactivated influenza virosome vaccine containing an enzymatically active Escherichia coli Heat Labile Toxin (LT ...
Kromann Ingrid   +35 more
core   +2 more sources

Willingness to pay for oral cholera vaccines in urban Bangladesh [PDF]

open access: yesPLOS ONE, 2020
Introduction Cholera is a highly infectious disease and remains a serious public health burden in Bangladesh. The objective of the study was to measure the private demand for oral cholera vaccines (OCV) in Bangladesh and to investigate the key determinants of this demand, reflected in the household's willingness to pay (WTP) for oral cholera vaccine ...
Abdur Razzaque Sarker   +11 more
openaire   +7 more sources

Urban Cholera transmission hotspots and their implications for Reactive Vaccination: evidence from Bissau city, Guinea Bissau [PDF]

open access: yes, 2012
Use of cholera vaccines in response to epidemics (reactive vaccination) may provide an effective supplement to traditional control measures. In Haiti, reactive vaccination was considered but, until recently, rejected in part due to limited global supply ...
Lessler, Justin   +45 more
core   +2 more sources

Development of Hillchol (R), a low-cost inactivated single strain Hikojima oral cholera vaccine [PDF]

open access: yes, 2020
Cholera remains an important global health problem with up to 4 million cases and 140,000 deaths annually. Oral cholera vaccines (OCVs) are now a cornerstone of the WHOs "Ending Cholera - A Global Roadmap to 2030" global program for the eventual ...
Ahasan, M. M.   +14 more
core   +1 more source

Home - About - Disclaimer - Privacy